![Seth M. Birnbaum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seth M. Birnbaum
Direttore/Membro del Consiglio presso Hallux, Inc.
Posizioni attive di Seth M. Birnbaum
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hallux, Inc.
![]() Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Direttore/Membro del Consiglio | 18/05/2022 | - |
Storia della carriera di Seth M. Birnbaum
Formazione di Seth M. Birnbaum
Amherst College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Hallux, Inc.
![]() Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Health Technology |
- Borsa valori
- Insiders
- Seth M. Birnbaum
- Esperienza